Rebamipide: a gastrointestinal protective drug with pleiotropic activities (Q43042896)

12 November 2017

Rebamipide: a gastrointestinal protective drug with pleiotropic activities (English)

1 reference

12 November 2017

1 reference

Yuji Naito

1

1 reference

PubMed ID

20528113

12 November 2017

Toshikazu Yoshikawa

series ordinal

2

1 reference

12 November 2017

1 June 2010

1 reference

Expert Review of Gastroenterology & Hepatology

12 November 2017

1 reference

12 November 2017

4

1 reference

12 November 2017

261-270

1 reference

12 November 2017

3

1 reference

Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test

12 November 2017

1 reference

Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats

21 January 2018

1 reference

Effect of rebamipide on prostaglandin EP4 receptor gene expression in rat gastric mucosa

21 January 2018

1 reference

Mechanism of hydroxyl radical scavenging by rebamipide: identification of mono-hydroxylated rebamipide as a major reaction product

21 January 2018

1 reference

Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats

21 January 2018

1 reference

Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants

21 January 2018

1 reference

Expression of cyclooxygenase-2 in human neutrophils activated by Helicobacter pylori water-soluble proteins: possible involvement of NF-kappaB and MAP kinase signaling pathway

21 January 2018

1 reference

Significance of ERK nitration in portal hypertensive gastropathy and its therapeutic implications

21 January 2018

1 reference

Rebamipide-promoted restoration of gastric mucosal sonic hedgehog expression after early Helicobacter pylori eradication.

21 January 2018

1 reference

Bioequivalence of rebamipide granules and tablets in healthy adult male volunteers.

21 January 2018

1 reference

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver

21 January 2018

1 reference

Pharmacokinetic drug interaction profiles of proton pump inhibitors

21 January 2018

1 reference

15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications

21 January 2018

1 reference

Intestinal mucosal barrier function in health and disease

21 January 2018

1 reference

Prophylactic effect of rebamipide on aspirin-induced gastric lesions and disruption of tight junctional protein zonula occludens-1 distribution

21 January 2018

1 reference

Oxidative stress induces gastric epithelial permeability through claudin-3.

21 January 2018

1 reference

Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs

21 January 2018

1 reference

Transcriptome Analysis for Cytoprotective Actions of Rebamipide against Indomethacin-Induced Gastric Mucosal Injury in Rats.

21 January 2018

1 reference

Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced rat colitis

21 January 2018

1 reference

Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats

21 January 2018

1 reference

Effect of rectal administration of rebamipide on dextran sulfate sodium-induced colitis: role of hepatocyte growth factor.

21 January 2018

1 reference

Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B.

21 January 2018

1 reference

Rebamipide inhibits gastric cancer cell growth

21 January 2018

1 reference

Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study

21 January 2018

1 reference

A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide

21 January 2018

1 reference

Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection--a randomized controlled study

21 January 2018

1 reference

Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection

21 January 2018

1 reference

Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan

21 January 2018

1 reference

An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors

21 January 2018

1 reference

Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study

21 January 2018

1 reference

Prevention of Indomethacin-Induced Gastric Mucosal Injury in Helicobacter pylori-Negative Healthy Volunteers: A Comparison Study Rebamipide vs Famotidine

21 January 2018

1 reference

Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDY.

21 January 2018

1 reference

Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study

21 January 2018

1 reference

Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study

21 January 2018

1 reference

Protective effect of rebamipide on indomethacin-induced intestinal damage in rats

21 January 2018

1 reference

Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study

21 January 2018

1 reference

Efficacy of rebamipide enemas in active distal ulcerative colitis and proctitis: a prospective study report

21 January 2018

1 reference

Rebamipide enemas-new effective treatment for patients with corticosteroid dependent or resistant ulcerative colitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.10.25

1 reference

12 November 2017

1 reference

PubMed ID

20528113